Dr. Jennifer Zon

Family Medicine
Baylor Scott & White Urgent Care Dallas (Mockingbird)
6350 E Mockingbird Ln, 
Dallas, TX 
Baylor Scott & White Urgent Care Dallas (Mockingbird)
6350 E Mockingbird Ln, 
Dallas, TX 

Overview

Jennifer Zon is a primary care provider, practicing in Family Medicine in Dallas, Texas.

She is actively involved in clinical research, participating in 8 clinical trials.

Specialties

Family Medicine

Licenses

Family Medicine in TX

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Baylor Scott & White Urgent Care Dallas (Mockingbird)
6350 E Mockingbird Ln, Dallas, TX 75214

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Safety, Tolerability, and Pharmacokinetic Study of 1- and 2-mL Injections of LY3074828 Solution Using Investigational Pre-filled Syringes and Investigational Autoinjectors in Healthy Subjects
A Safety, Tolerability, and Pharmacokinetic Study of 1- and 2-mL Injections of LY3074828 Solution Using Investigational Pre-filled Syringes and Investigational Autoinjectors in Healthy Subjects
Enrollment Status: Completed
Publish Date: February 20, 2024
Intervention Type: Biological
Study Phase: Phase 1
A Randomized Study to Investigate Injection-Site Pain Following Subcutaneous Injections of 2 Ixekizumab Test Formulations Compared to the Commercial Formulation Using a Pre-filled Syringe in Healthy Subjects
A Randomized Study to Investigate Injection-Site Pain Following Subcutaneous Injections of 2 Ixekizumab Test Formulations Compared to the Commercial Formulation Using a Pre-filled Syringe in Healthy Subjects
Enrollment Status: Terminated
Publish Date: November 30, 2022
Intervention Type: Biological
Study Phase: Phase 1
A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Induction Dosing Period Followed by a Randomized Withdrawal Maintenance Dosing Period to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-1
A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Induction Dosing Period Followed by a Randomized Withdrawal Maintenance Dosing Period to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-1
Enrollment Status: Completed
Publish Date: September 25, 2020
Intervention Type: Drug
Study Phase: Phase 3
A First-In-Human, Phase 1, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GFB-887, a TRPC5 Channel Inhibitor, in Healthy Subjects
A First-In-Human, Phase 1, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GFB-887, a TRPC5 Channel Inhibitor, in Healthy Subjects
Enrollment Status: Completed
Publish Date: June 02, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Open-Label, Fixed-sequence, 5-part, Drug-drug Interaction Study of Tucatinib to Evaluate the Effects of CYP3A4 and CYP2C8 Inhibition and Induction on the Pharmacokinetics of Tucatinib and to Evaluate the Effects of Tucatinib on the Pharmacokinetics of Substrates of CYP3A4, CYP2C8, CYP2C9, and P-glycoprotein in Healthy Male and Female Subjects
A Phase 1, Open-Label, Fixed-sequence, 5-part, Drug-drug Interaction Study of Tucatinib to Evaluate the Effects of CYP3A4 and CYP2C8 Inhibition and Induction on the Pharmacokinetics of Tucatinib and to Evaluate the Effects of Tucatinib on the Pharmacokinetics of Substrates of CYP3A4, CYP2C8, CYP2C9, and P-glycoprotein in Healthy Male and Female Subjects
Enrollment Status: Completed
Publish Date: December 18, 2019
Intervention Type: Drug
Study Phase: Phase 1
A Safety, Tolerability, and Pharmacokinetic Study of Different Solution Formulations of LY3375880 Using Investigational Injection Devices in Healthy Subjects
A Safety, Tolerability, and Pharmacokinetic Study of Different Solution Formulations of LY3375880 Using Investigational Injection Devices in Healthy Subjects
Enrollment Status: Completed
Publish Date: October 11, 2019
Intervention Type: Device, Drug
Study Phase: Phase 1
A Phase 1, Randomized, Partially Double-Blind, Placebo- and Positive-controlled Study to Evaluate the Effect of Tucatinib on Cardiac Repolarization in Healthy Subjects
A Phase 1, Randomized, Partially Double-Blind, Placebo- and Positive-controlled Study to Evaluate the Effect of Tucatinib on Cardiac Repolarization in Healthy Subjects
Enrollment Status: Completed
Publish Date: April 12, 2019
Intervention Type: Drug
Study Phase: Phase 1
View 6 Less Clinical Trials
Similar Doctors
Expertise in
127
conditions
Dr. Charles Powell
Family Medicine
Expertise in
127
conditions
Dr. Charles Powell
Family Medicine

Office

1110 Cottonwood Ln Ste 100, 
Irving, TX 
 (14.4 miles away)
972-258-7499
Languages Spoken:
English
See accepted insurances

Charles Powell is a primary care provider, practicing in Family Medicine in Irving, Texas. Dr. Powell is highly rated in 127 conditions, according to our data. His clinical expertise encompasses Familial Hypertension, Hypertension, Glucocorticoid-Remediable Aldosteronism, and High Cholesterol.

Expertise in
19
conditions
Dr. Eduardo Lindsay
Family Medicine
Expertise in
19
conditions
Dr. Eduardo Lindsay
Family Medicine

Lydia O. Njamfa Md.Pa

708 W Spring Valley Rd, 
Richardson, TX 
 (7.2 miles away)
214-570-9400
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Eduardo Lindsay is a primary care provider, practicing in Family Medicine in Richardson, Texas. Dr. Lindsay is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Osteomyelitis in Children, Osteomyelitis, Acanthosis Nigricans, and Type A Insulin Resistance Syndrome.

Expertise in
17
conditions
Dr. Shahida Rafiq
Family Medicine
Expertise in
17
conditions
Dr. Shahida Rafiq
Family Medicine

Wound Care Clinic At Texas Health Dallas

8198 Walnut Hill Ln, Jackson Bldg Wound Care Clinic, 
Dallas, TX 
 (3.3 miles away)
214-345-4334
Languages Spoken:
English, Hindi, Urdu
See accepted insurances

Shahida Rafiq is a primary care provider, practicing in Family Medicine in Dallas, Texas. Dr. Rafiq is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Cellulitis, Peptic Ulcer, Necrosis, Paraplegia, and Gastrostomy.

Frequently Asked Questions about Dr. Jennifer Zon

How do I make an appointment with Dr. Jennifer Zon?

You can book an appointment with Dr. Jennifer Zon by calling their office at 214-828-0448. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Zon's expertise for a condition
ConditionClose

We do not have enough information to identify the Areas of Expertise for this provider.

Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile